HemaXis DB10 for sport
Simplifying in-competition drug testing
In-competition blood testing is a powerful tool allowing an athlete’s health monitoring or drug consumption when risks and stressors are the highest. Only blood permits the determination of the health status and drug consumption at any given time. Urine may reflect a wider time window in the past but is subject to several biases. However, conventional venepuncture procedures has generally excluded blood sampling from in-competition testing. But now, HemaXis DB10 empowers blood testing in such a constrained environment.
Tramadol testing in professional cycling
As of March 1st 2019, the Union Cycliste Internationale (UCI) banned in-competition use of tramadol across all cycling disciplines. Tramadol is a commonly available pain killer (opioid) that induces dependence, drowsiness and concentration deficits. The use of such a drug greatly increases crash risks and health issues. Controls are now common in professional cycling, especially in the pinnacle of competitions: WorldTour stage races where riders are sampled upon race completion, thanks to the use of HemaXis.
The Research and Expertise in anti-Doping sciences (REDs) from the University of Lausanne was mandated by the UCI to develop and validate an analytical method to monitor Tramadol misuse and to coordinate the field operational implementation in collaboration with the Cycling Anti-Doping Foundation (CADF).
HemaXis DB10 was selected as the ideal tool to perform reliable, fast and minimally invasive blood sampling at the finish line. Additionally, the generation of Dried Blood Spots (DBS) allows more compact storage, easier transport and more stable samples. Overall, the use of HemaXis DB10 is a cheap and convenient in-competition blood sampling solution.
Glimpse of the testing program
The testing program has been continued through the 2019 season and beyond.
“Our need for an efficient in-competition blood sampling solution led to a partnership with DBS System. HemaXis DB10 enables the collection of reliable capillary blood samples in a minimally invasive way that is compatible with precise laboratory analyses.”
Prof. Martial Saugy
Head of Research and Expertise in anti-Doping Sciences (REDs) in University of Lausanne
Advantages of HemaXis DB10
The HemaXis DB10 collection device uses patented microfluidic technology to simplify all steps of blood analysis.
HemaXis DB10 enables the collection of a controlled volume of blood from a simple prick at the patient’s fingertip. The blood sample is then directly transferred onto a filter paper card, without the need for any other equipment (precision pipette, glass capillary, etc). The collection can be done by anyone after rapid training.
Once dried, the contamination risk by blood borne pathogenes is limited, and samples are stable. HemaXis DB10 devices can be shipped for analysis to the laboratory.
Blood samples can be collected quickly and easily at the patient’s fingertip
Samples can be quickly analyzed in the lab using automated processes, or easily stored for later use
Samples can be stored at room temperature and shipped by standard mail service to the lab
The standardization of sample collection using HemaXis™ DB10 guaranties quantitation accuracy and precision
Blood drug testing is Easier and More Efficient with HemaXis DB10
With HemaXis DB10, blood is easily collected at the fingertip, which makes it the ideal device for on-field collection in sport. It opens the way to simpler and reliable testing on athletes that are monitored in registered pools or sampled in-competition.
Start Using HemaXis DB10
Contact us for more information on how to integrate HemaXis DB10 into your workflow.